Nevirapine
- Product NDC
- 0781-5893
- 11-digit product format
- 007815893
- Labeler code
- 0781
- Product ID
- 0781-5893_71d555c0-49ff-4c9b-a3ee-dbbe89efbf5f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nevirapine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Sandoz Inc
- Application
- ANDA203411
- Marketing category
- ANDA
- Marketing start
- 2014-04-15
- Marketing end
- 0000-00-00
- Substance
- NEVIRAPINE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0781-5893-05 | 00781589305 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0781-5893-05) | 2014-04-15 | 0000-00-00 | No | No | Current |
| 0781-5893-31 | 00781589331 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0781-5893-31) | 2014-04-15 | 0000-00-00 | No | No | Current |